| Rosalee K Rehrig, DO | |
|
1976 West Penn Pike, New Ringgold, PA 17960 | |
| (570) 386-8861 | |
| (570) 386-8862 |
| Full Name | Rosalee K Rehrig |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 24 Years |
| Location | 1976 West Penn Pike, New Ringgold, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043277668 | NPI | - | NPPES |
| 0019555400001 | Medicaid | PA | |
| 1019671310001 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | OS 011171L (Pennsylvania) | Secondary |
| 207Q00000X | Family Medicine | OS-011171-L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Geisiner Home Health | Hazleton, PA | Home health agency |
| Helping Hand Hospice, Inc | Philadelphia, PA | Hospice |
| St Luke's Miners Memorial Hospital | Coaldale, PA | Hospital |
| Lehigh Valley Hospital | Allentown, PA | Hospital |
| St Luke's Hospital Bethlehem | Bethlehem, PA | Hospital |
| Schuylkill Medical Center - South Jackson Street | Pottsville, PA | Hospital |
| Entity Name | The Carbon-schuylkill Community Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194891010 PECOS PAC ID: 4486562030 Enrollment ID: O20031117000015 |
News Archive
Working in collaboration with Kiel University, researchers at the Kiel- based Collagen Research Institute (CRI) have demonstrated the stimulating effect of special bioactive collagen peptides (FORTIGEL(R)) in the context of cell experiments. Last weekend the CRI presented its research findings at the congress of the Osteoarthritis Research Society International (OARSI) in Montreal.
Individuals with mutations in BRCA1 and BRCA2 genes have a significantly higher risk of developing breast and ovarian cancers. Families at risk have been seeking genetic testing and counseling based on their mutation carrier status, but the standard method of direct sequencing is labor-intensive, costly, and it only targets a part of the BRCA1 and BRCA2 genes.
Millennium Laboratories, a leading provider of therapeutic drug monitoring and education to physicians and staff treating chronic pain patients, has announced the launch of an advocacy campaign to fight reimbursement cuts to point-of-care (POC) urine drug screen devices.
Researchers at the University of Leicester have worked with Northamptonshire Police's Scientific Support Unit to research whether or not drug-dependent offenders were more likely to be apprehended through forensic science techniques than those who were not.
› Verified 1 days ago
| Entity Name | Rosalee Rehrig D.o., P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073708731 PECOS PAC ID: 8921195371 Enrollment ID: O20071101000032 |
News Archive
Working in collaboration with Kiel University, researchers at the Kiel- based Collagen Research Institute (CRI) have demonstrated the stimulating effect of special bioactive collagen peptides (FORTIGEL(R)) in the context of cell experiments. Last weekend the CRI presented its research findings at the congress of the Osteoarthritis Research Society International (OARSI) in Montreal.
Individuals with mutations in BRCA1 and BRCA2 genes have a significantly higher risk of developing breast and ovarian cancers. Families at risk have been seeking genetic testing and counseling based on their mutation carrier status, but the standard method of direct sequencing is labor-intensive, costly, and it only targets a part of the BRCA1 and BRCA2 genes.
Millennium Laboratories, a leading provider of therapeutic drug monitoring and education to physicians and staff treating chronic pain patients, has announced the launch of an advocacy campaign to fight reimbursement cuts to point-of-care (POC) urine drug screen devices.
Researchers at the University of Leicester have worked with Northamptonshire Police's Scientific Support Unit to research whether or not drug-dependent offenders were more likely to be apprehended through forensic science techniques than those who were not.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rosalee K Rehrig, DO 1976 West Penn Pike, New Ringgold, PA 17960 Ph: (570) 386-8861 | Rosalee K Rehrig, DO 1976 West Penn Pike, New Ringgold, PA 17960 Ph: (570) 386-8861 |
News Archive
Working in collaboration with Kiel University, researchers at the Kiel- based Collagen Research Institute (CRI) have demonstrated the stimulating effect of special bioactive collagen peptides (FORTIGEL(R)) in the context of cell experiments. Last weekend the CRI presented its research findings at the congress of the Osteoarthritis Research Society International (OARSI) in Montreal.
Individuals with mutations in BRCA1 and BRCA2 genes have a significantly higher risk of developing breast and ovarian cancers. Families at risk have been seeking genetic testing and counseling based on their mutation carrier status, but the standard method of direct sequencing is labor-intensive, costly, and it only targets a part of the BRCA1 and BRCA2 genes.
Millennium Laboratories, a leading provider of therapeutic drug monitoring and education to physicians and staff treating chronic pain patients, has announced the launch of an advocacy campaign to fight reimbursement cuts to point-of-care (POC) urine drug screen devices.
Researchers at the University of Leicester have worked with Northamptonshire Police's Scientific Support Unit to research whether or not drug-dependent offenders were more likely to be apprehended through forensic science techniques than those who were not.
› Verified 1 days ago